Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group.

Autor:	Colling R; Nuffield Department of Surgical Sciences, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, United Kingdom; Department of Cellular Pathology, Oxford University Hospitals NHS FT, Oxford, United Kingdom. Electronic address: richard.colling@nds.ox.ac.uk., Indave I; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Del Aguilla J; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Cierco Jimenez R; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Campbell F; Population Health Sciences, Newcastle University, Newcastle Upon Tyne, United Kingdom., Chechlinska M; Department of Cancer Biology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Kowalewska M; Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Holdenrieder S; Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany., Trulson I; Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany., Worf K; Institute of Laboratory Medicine, German Heart Centre Munich, Munich, Germany., Pollán M; National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Plans-Beriso E; National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain., Pérez-Gómez B; National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Craciun O; National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain., García-Ovejero E; National Center for Epidemiology. Instituto de Salud Carlos III, Madrid, Spain., Michalek IM; Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Maslova K; Department of Cancer Biology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Rymkiewicz G; Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Didkowska J; Polish National Cancer Registry, Department of Epidemiology and Cancer Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Tan PH; Luma Medical Centre, Singapore, Singapore., Diyana Bte Md Nasir N; Luma Medical Centre, Singapore, Singapore., Myles N; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Giesen C; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Goldman-Lévy G; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Lokuhetty D; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France., Cree IA; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
Jazyk:	angličtina
Zdroj:	Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Jul; Vol. 37 (7), pp. 100515. Date of Electronic Publication: 2024 May 17.
DOI:	10.1016/j.modpat.2024.100515
Abstrakt:	Evidence-based medicine (EBM) can be an unfamiliar territory for those working in tumor pathology research, and there is a great deal of uncertainty about how to undertake an EBM approach to planning and reporting histopathology-based studies. In this article, reviewed and endorsed by the Word Health Organization International Agency for Research on Cancer's International Collaboration for Cancer Classification and Research, we aim to help pathologists and researchers understand the basics of planning an evidence-based tumor pathology research study, as well as our recommendations on how to report the findings from these. We introduce some basic EBM concepts, a framework for research questions, and thoughts on study design and emphasize the concept of reporting standards. There are many study-specific reporting guidelines available, and we provide an overview of these. However, existing reporting guidelines perhaps do not always fit tumor pathology research papers, and hence, here, we collate the key reporting data set together into one generic checklist that we think will simplify the task for pathologists. The article aims to complement our recent hierarchy of evidence for tumor pathology and glossary of evidence (study) types in tumor pathology. Together, these articles should help any researcher get to grips with the basics of EBM for planning and publishing research in tumor pathology, as well as encourage an improved standard of the reports available to us all in the literature. (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu